Anebulo Pharmaceuticals, Inc. (ANEB): Total Liabilities
$487.7K
As of 2025-06-30
$1.49M
As of 2025-12-31
-1.6%
3-year compound annual growth
+16.9%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-06-30 | $487.7K | +87.2% | 2025-09-29, Balance as of period end |
| 2024-06-30 | $260.6K | -75.6% | 2025-09-29, Balance as of period end |
| 2023-06-30 | $1.07M | +108.5% | 2024-09-25, Balance as of period end |
| 2022-06-30 | $512.5K | +112.1% | 2023-09-22, Balance as of period end |
| 2021-06-30 | $241.6K | +7.9% | 2022-09-09, Balance as of period end |
| 2020-06-30 | $223.9K | n/a | 2021-09-22, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Anebulo Pharmaceuticals, Inc. (ANEB) | 2025-06-30 | $487.7K | +87.2% |
| Turn Therapeutics Inc. (TTRX) | 2025-12-31 | $7.48M | +235.8% |
| Imunon, Inc. (IMNN) | 2025-12-31 | $5.23M | -4.5% |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $2.71M | +0.3% |
| Nomad Power Solutions, Inc. (NMAD) | 2025-12-31 | $1.77M | +456.8% |
| Revelation Biosciences, Inc. (REVB) | 2025-12-31 | $2.72M | +42.2% |
| Curanex Pharmaceuticals Inc (CURX) | 2025-12-31 | $361.0K | n/m |
| Propanc Biopharma, Inc. (PPCB) | 2026-06-30 | $3.38M | -41.0% |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $5.03M | +115.6% |
Compare ANEB, TTRX, IMNN, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗